Prevalence and factors associated with suboptimal adherence to dolutegravir-based regimens among people living with HIV in a specialized clinic in Kampala, Uganda

Author:

Namakula Edith1,Mugerwa Henry2,Kitutu Freddy3,Kawuma Aida N4,Kiguba Ronald3,Kalyango Joan N3

Affiliation:

1. Mulago National Referral Hospital

2. Joint Clinical Research Centre

3. Makerere University

4. Infectious Diseases Institute

Abstract

Abstract Background Suboptimal adherence to dolutegravir is up to 31% globally. In Uganda, 54% of people living with HIV(PLHIV) on first-line Antiretroviral Therapy (ART) were taking dolutegravir-based regimens. This study aimed to determine the prevalence and factors associated with suboptimal adherence to dolutegravir-based regimens in PLHIV in a specialized clinic in Uganda. Methods We conducted a cross-sectional study with both quantitative and qualitative aspects in a specialized HIV clinic in Kampala, Uganda, from July 2022 to August 2022. We collected quantitative data, using questionnaires, and data abstraction tools; from 366, consecutively sampled, and consented PLHIV. We collected qualitative data using in-depth interviews, among 13 purposively sampled, consented participants. We analyzed quantitative data using modified Poisson regression in STATA, to obtain factors associated with suboptimal adherence at the 5% level of significance. Qualitative data was analyzed using thematic analysis in Open Code. Results The prevalence of suboptimal adherence to dolutegravir-based regimens was 49% (179/366; 95%Confidence Interval (CI): 44–54). Alcohol consumption (adjusted Prevalence Ratio (aPR): 1.25; 95%CI: 1.012–1.543), being unemployed (aPR: 1.27; 95%CI: 1.002–1.609), not having neighbor’s support (aPR: 0.78; 95%CI: 0.619–0.993), and participants who preferred to talk to the doctor in case of a health problem (aPR: 0.44; 95%CI: 0.307–1.270) were associated with suboptimal adherence, to dolutegravir-based ART regimens. Barriers to dolutegravir adherence included: unemployment, lack of social support, alcohol consumption, and inadequate counselling. Conclusion Suboptimal adherence to dolutegravir-based ART was high. PLHIV should start-up projects that are economically viable. Dolutegravir-related virological failure in PLHIV should be investigated.

Publisher

Research Square Platform LLC

Reference29 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3